GCIA
SYNH

Gabelli & Co Investment Advisers’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-180,900
Closed -$7.62M – 273
2023
Q2 		$7.62M Buy
+180,900
New +$7.31M 1.28% 22

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's SYNH Position: Q3 2023 in Review

Gabelli & Co Investment Advisers sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 180,900 shares — an estimated $7.62M sold.

Gabelli & Co Investment Advisers first reported a position in SYNH in Q2 2023 and held it in 1 quarter. The position peaked at $7.62M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Gabelli & Co Investment Advisers reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 180,900 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $7.62M.
  • Gabelli & Co Investment Advisers first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Syneos Health, Inc. Class A Common Stock position peaked at $7.62M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.